Literature DB >> 21922068

GAD65 antibodies, chronic psychosis, and type 2 diabetes mellitus.

Atmaram Yarlagadda1, Jerome H Taylor, Christiane S Hampe, Elizabeth Alfson, Anita H Clayton.   

Abstract

Glutamic acid decarboxylase is the rate-limiting enzyme in the production of gamma aminobutyric acid, an inhibitory neurotransmitter. Autoantibodies to the glutamic acid decarboxylase 65 isoform have been associated with chronic psychotic disorders and are found in neurons and pancreatic islets. Blood samples were collected from normal controls (n=16), individuals with chronic psychosis with type 2 diabetes mellitus (n=3), and patients with chronic psychosis without diabetes (n=8). No differences were found between any of the groups for frequency of positive glutamic acid decarboxylase 65Ab samples (98th percentile of a healthy control group) or in mean values of glutamic acid decarboxylase 65Ab. Sample size was likely too small to detect differences if they do exist.

Entities:  

Keywords:  GAD65 autoantibodies; GAD65Ab; Glutamic acid decarboxylase; diabetes; psychosis

Year:  2011        PMID: 21922068      PMCID: PMC3173753     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  18 in total

1.  Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.

Authors:  C S Hampe; L P Hammerle; L Bekris; E Ortqvist; I Kockum; O Rolandsson; M Landin-Olsson; C Törn; B Persson; A Lernmark
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

2.  Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase.

Authors:  S Baekkeskov; H J Aanstoot; S Christgau; A Reetz; M Solimena; M Cascalho; F Folli; H Richter-Olesen; P De Camilli; P D Camilli
Journal:  Nature       Date:  1990-09-13       Impact factor: 49.962

3.  Species-specific autoantibodies in type 1 diabetes.

Authors:  C S Hampe; E Ortqvist; O Rolandsson; M Landin-Olsson; C Törn; A Agren; B Persson; D B Schranz; A Lernmark
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958

4.  Differential localization of two glutamic acid decarboxylases (GAD65 and GAD67) in adult monkey visual cortex.

Authors:  A E Hendrickson; N J Tillakaratne; R D Mehra; M Esclapez; A Erickson; L Vician; A J Tobin
Journal:  J Comp Neurol       Date:  1994-05-22       Impact factor: 3.215

5.  Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene.

Authors:  D F Bu; M G Erlander; B C Hitz; N J Tillakaratne; D L Kaufman; C B Wagner-McPherson; G A Evans; A J Tobin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

6.  Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.

Authors:  K Dinkel; H M Meinck; K M Jury; W Karges; W Richter
Journal:  Ann Neurol       Date:  1998-08       Impact factor: 10.422

7.  A high prevalence of organ-specific autoimmunity in patients with bipolar disorder.

Authors:  Roos C Padmos; Lynn Bekris; Esther M Knijff; Henning Tiemeier; Ralph W Kupka; Dan Cohen; Willem A Nolen; Ake Lernmark; Hemmo A Drexhage
Journal:  Biol Psychiatry       Date:  2004-10-01       Impact factor: 13.382

8.  Differential expression of glutamic acid decarboxylase in rat and human islets.

Authors:  J S Petersen; S Russel; M O Marshall; H Kofod; K Buschard; N Cambon; A E Karlsen; E Boel; W A Hagopian; K R Hejnaes
Journal:  Diabetes       Date:  1993-03       Impact factor: 9.461

9.  Glutamic acid decarboxylase (GAD) antibodies in tardive dyskinesia (TD) as compared to patients with schizophrenia without TD and normal controls.

Authors:  Atmaram Yarlagadda; Badalin Helvink; Caroline Chou; Kenneth Gladieux; Adrienne Keller; Anita Clayton
Journal:  Schizophr Res       Date:  2008-08-16       Impact factor: 4.939

10.  Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10.

Authors:  A E Karlsen; W A Hagopian; C E Grubin; S Dube; C M Disteche; D A Adler; H Bärmeier; S Mathewes; F J Grant; D Foster; Åke Lernmark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

View more
  1 in total

1.  Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study.

Authors:  Jerome H Taylor; Ewgeni Jakubovski; Daniel Gabriel; Michael H Bloch
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-06-19       Impact factor: 2.576

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.